SCHEMBL16265647

SCHEMBL16265647

CCOC(=O)C(C)CN1CCN([Si](CC(C)C)(CC(C)C)CC(C)C)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.38
CYP2C19 P33261 1/20 0.38
GAA P10253 1/20 0.37
PIK3CD O00329 1/20 0.36
MAPT P10636 3/20 0.34
ALDH1A1 P00352 6/20 0.33
KDM4E B2RXH2 1/20 0.33
CHRM2 P08172 2/20 0.32
ADRA2B P18089 2/20 0.32
DRD3 P35462 2/20 0.32
SIGMAR1 Q99720 2/20 0.32
HRH3 Q9Y5N1 2/20 0.32
LMNA P02545 3/20 0.31
KMT2A Q03164 2/20 0.31
HPGD P15428 1/20 0.31
RAB9A P51151 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
CYP2D6 P10635 3/20 0.31
ADRA2C P18825 1/20 0.31
CHRM3 P20309 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16265740 0.92 CYP3A4 (0.36) CYP3A4CYP2C19GAAPIK3CDMAPT
SCHEMBL16265828 0.88 CYP3A4 (0.39) CYP3A4CYP2C19GAAPIK3CDMAPT
SCHEMBL16265872 0.87 PIK3CD (0.37) GAAPIK3CDALDH1A1CHRM2ADRA2B
SCHEMBL16265479 0.83 CYP3A4 (0.35) CYP3A4CYP2C19GAAALDH1A1KDM4E
SCHEMBL16265608 0.83 CYP3A4 (0.43) CYP3A4CYP2C19GAAPIK3CDMAPT
SCHEMBL16265792 0.82 CYP3A4 (0.39) CYP3A4CYP2C19GAAPIK3CDMAPT
SCHEMBL16265695 0.79 CYP3A4 (0.38) CYP3A4CYP2C19GAAMAPTALDH1A1
SCHEMBL16265615 0.79 CYP3A4 (0.38) CYP3A4CYP2C19GAAPIK3CDMAPT
SCHEMBL16265754 0.78 POLB (0.32) PIK3CDCYP2D6
SCHEMBL16265543 0.78 CYP3A4 (0.40) CYP3A4CYP2C19GAAPIK3CDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2808329-B1 Silyl-Protected Nitrogen-Containing Cyclic Compounds and their method of preparation SHINETSU CHEMICAL CO (JP) 2018-09-26 EP disclosed
US-9233988-B2 Silyl-protected nitrogen-containing cyclic compounds and making method SHIN-ETSU CHEMICAL CO., LTD. (JP) 2016-01-12 US disclosed
CN-104211725-A Silyl-protected nitrogen-containing cyclic compounds and making method SHINETSU CHEMICAL CO 2014-12-17 CN disclosed
US-20140357862-A1 SILYL-PROTECTED NITROGEN-CONTAINING CYCLIC COMPOUNDS AND MAKING METHOD SHIN-ETSU CHEMICAL CO., LTD. (JP) 2014-12-04 US disclosed
EP-2808329-A1 Silyl-Protected Nitrogen-Containing Cyclic Compounds and Making Method Shin-Etsu Chemical Co., Ltd. (JP) 2014-12-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140357862-A1 SILYL-PROTECTED NITROGEN-CONTAINING CYCLIC COMPOUNDS AND MAKING METHOD PRMT9, CCNO, IPO9 CYP3A4 2494/4885CYP2C19 1911/4885GAA 4605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.